Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2018
|
| gptkbp:ATCCode |
N02CD05
|
| gptkbp:developedBy |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:drugClass |
gptkb:monoclonal_antibody
|
| gptkbp:form |
solution for injection
pre-filled syringe |
| gptkbp:genericName |
gptkb:fremanezumab
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ajovy
|
| gptkbp:indication |
migraine prevention
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedIn |
gptkb:European_Union
gptkb:United_States |
| gptkbp:mechanismOfAction |
CGRP antagonist
|
| gptkbp:pregnancyCategory |
not assigned
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
hypersensitivity
injection site reactions |
| gptkbp:target |
gptkb:calcitonin_gene-related_peptide_(CGRP)
|
| gptkbp:bfsParent |
gptkb:Teva_Pharmaceutical_Industries
|
| gptkbp:bfsLayer |
5
|